New plans will be reviewed today for two ten-story R&D buildings at 100 East Grand Avenue in South San Francisco, San Mateo County. The project will replace low-slung commercial structures with modern new life science offices, further expanding the city’s burgeoning biotech industry. Alexandria Real Estate Equities is the project applicant.
Alexandria Real Estate Equities
Curtainwall installation has finished for 751 Gateway Boulevard, one of a few R&D offices rising in South San Francisco’s East Side neighborhood. The project has replaced a surface parking lot while expanding the existing Gateway Campus opened by the co-owners Alexandria Real Estate Equities and Boston Properties.
Alexandria Real Estate Equities has secured a future long-term headquarters for Eikon Therapeutics. The new HQ will be in the Millbrae Offices and Life Sciences campus, currently under construction across from the Millbrae Train Station. The company will be moving to San Mateo County from its current location in Hayward.
The entitlement application is under review to replace a two-story office building with a nearly identically-sized project at 901 South California Avenue in Palo Alto, Santa Clara County. The property is within the Stanford Research Park, across from the College Terraces neighborhood. Alexandria Real Estate Equities is responsible for the application.
New renderings have been revealed for the proposed life sciences campus in Millbrae, San Mateo County. The project will add over half a million square feet with space for over two thousand employees, across from the mixed-use Gateway at Millbrae Station development. Greystar is partnering with Alexandria Real Estate Equities, a major investor in biotech projects across the nation.